Dr. Vishal Devarkonda, MD

Dr. Devarkonda practices at Louisiana State University Health Sciences Center Shreveport in Shreveport, Louisiana.

Dr. Devarkonda's NPI, 1932620663, was assigned on July 3, 2017. Dr. Devarkonda graduated from Sri Siddhartha Medical College in 2013. Dr. Devarkonda holds Louisiana license 324259.

Dr. Devarkonda's primary practice is Louisiana State University Health Sciences Center Shreveport, at 1541 Kings Hwy, Shreveport, LA 71103 in Caddo Parish. The practice phone is (318) 675-7205.

Dr. Devarkonda's primary practice is Louisiana State University Health Sciences Center Shreveport in Shreveport, Louisiana. Dr. Devarkonda is also affiliated with Ochsner LSU Health - Academic Medical Center. The medical group on file is LSU Health Shreveport.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devarkonda practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Devarkonda's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Devarkonda is licensed in Louisiana.

Dmand AI lists acute respiratory failure, acute skin infection, atrial fibrillation and flutter, bone infection, cardiac arrhythmia, chronic diabetes, chronic hypertension and electrolyte disorders among the conditions Dr. Devarkonda treats.

CMS data shows 343 Medicare services from Dr. Devarkonda across 4 procedure codes in 2024, for 94 Medicare patients. Medicare paid $24,448 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 94 Medicare patients who saw Dr. Devarkonda in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 63% are also on Medicaid. Their average risk score is 3.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Devarkonda's median patient age at 63, with 45% women.

In 2024, Dr. Devarkonda wrote 373 Medicare Part D claims for 121 patients. 85% of them were for generic drugs. CMS names the drug for 101 of them, across 4 drugs with 11 or more claims each, at $1,655 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

Dmand AI links 10 papers to Dr. Devarkonda, published from 2017 to 2025. 2023 was the busiest year, with 5. Dr. Devarkonda has published most often in Cureus. Dr. Devarkonda's most frequent co-authors are Hugo Akabane, MD, Shravya Balmuri, MD and Orimisan Samuel Adekolujo, MD.

CMS Open Payments shows 107 general payments to Dr. Devarkonda from 36 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 83% of the total. Janssen Pharmaceuticals, Inc paid the most, $459.

Dr. Devarkonda graduated from Sri Siddhartha Medical College in 2013.

Dr. Devarkonda is in network with 1 carrier, including Blue Cross and Blue Shield of Louisiana. POS plans come from the most carriers, 1. Check the plan with the practice before a visit.